News US regulator grants $23 million to rare disease R&D FDA announces 21 rare disease clinical trial research grants.
News Lundbeck epilepsy injection approved in US New carbamazepine formulation when oral dosing not feasible.
News New breakthrough designations for Roche's Alecensa and Actem... Alecensa and Roactemra are breakthroughs, says FDA.
News FDA launches genome sequencing app competition Winning apps will aid in the wider Precision Medicine Initiative.
News US and EU regulators collaborate on rare diseases Clinical trial design among areas regulators will collaborate on
News FDA launches app competition to take on opioid abuse 2016 Naloxone App Competition seeks app to connect opioid users with naloxone carriers.
News AbbVie's migraine drug cleared for migraine attacks on NHS AbbVie's Aquipta can now be commissioned by the NHS in England and Wales as an acute treatment for migraine, after a NICE decision.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
